Amgen Inc. (AMGN) News Headlines

▮ More

Date

Headline

9/13/2019 9:10:57 AM Amgen's Phase 3 CANDOR Study Meets Primary Endpoint Of PFS - Quick Facts

9/13/2019 9:02:24 AM Amgen : Phase 3 CANDOR Study Combining KYPROLIS And DARZALEX Meets Primary Endpoint Of Progression-Free Survival

9/12/2019 9:02:06 AM Amgen Says Highlights New Data From KYPROLIS And Oncology Pipeline At IMW 2019

9/10/2019 8:12:43 AM Amgen To Present At The Morgan Stanley Global Conference; Webcast At 9:10 AM ET

9/9/2019 1:44:46 AM Novartis: Aimovig Shows Long-term Efficacy In Treatment Of Episodic Migraine

9/8/2019 9:52:11 AM Amgen Drug Shrinks 54% Of Lung Cancer Tumors In Study

8/26/2019 7:04:31 AM Amgen To Acquire Otezla For $13.4 Billion In Cash - Quick Facts

8/26/2019 7:03:17 AM Amgen Investor Conference Call At 8:00 AM ET

8/26/2019 6:32:26 AM Amgen To Acquire Otezla For $13.4 Bln In Cash

8/23/2019 3:08:35 AM ALXN & Takeover Rumors, AMGN's JASMINE Blooms, CLSD Sees The Writing On The Wall

8/22/2019 9:23:39 AM Amgen: ABP 798 Shows Clinical Equivalence To Rituxan In Clinical Study

8/22/2019 9:01:57 AM Amgen And Allergan Announce Positive Top-line Results From Comparative Clinical Study Evaluating ABP 798

8/11/2019 11:08:10 PM Sandoz To Appeal U.S. Court Ruling In Biosimilar Erelzi U.S. Patent Case

8/9/2019 4:30:30 PM Amgen Wins Patent Case On Enbrel

8/2/2019 4:15:04 PM Amgen Declares Quarterly Dividend Of $1.45/share, Payable Sept. 6/ Record Aug. 15

8/2/2019 4:07:00 PM Amgen Inc. (AMGN) Declares Quarterly Dividend of $ 1.45, Record Date 8/15/2019

7/30/2019 4:05:12 PM Amgen Inc. Q2 adjusted earnings Beat Estimates

7/30/2019 4:04:00 PM Amgen Q2 Non-GAAP EPS Increase 4% To $3.97

7/30/2019 3:00:12 PM Amgen Q2 19 Earnings Conference Call At 5:30 PM ET

7/30/2019 6:06:22 AM Amgen Q2 19 Earnings Conference Call At 5:30 PM ET